Regular Article
Ataxia-Telangiectasia: Phenotype/Genotype Studies of ATM Protein Expression, Mutations, and Radiosensitivity

https://doi.org/10.1006/mgme.2000.2998Get rights and content

Abstract

Previous studies on a limited number of ataxia-telangiectasia (A-T) patients with detectable levels of intracellular ATM protein have suggested a genotype/phenotype correlation. We sought to elucidate this possible correlation by comparing ATM protein levels with mutation types, radiosensitivity, and clinical phenotype. In this study, Western blot analysis was used to measure ATM protein in lysates of lymphoblastoid cell lines (LCLs) from 123 unrelated A-T patients, 10 A-T heterozygotes, and 10 patients with phenotypes similar to A-T. Our Western blot protocol can detect the presence of ATM protein in as little as 1 μg of total protein; at least 25 μg of protein was tested for each individual. ATM protein was absent in 105 of the 123 patients (85%); most of these patients had truncating mutations. The remaining subset of 18 patients (15%) had reduced levels of normal-sized ATM protein; missense mutations were more common in this subset. We used a colony survival assay to characterize the phenotypic response of the LCLs to radiation exposure; patients with or without detectable ATM protein were typically radiosensitive. Nine of 10 A-T heterozygotes also had reduced expression of ATM, indicating that both alleles contribute to ATM protein production. These data suggest that although ATM-specific mRNA is abundant in A-T cells, the abnormal ATM protein is unstable and is quickly targeted for degradation. We found little correlation between level of ATM protein and the type of underlying mutation, the clinical phenotype, or the radiophenotype.

References (62)

  • R Varon et al.

    Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen Breakage Syndrome

    Cell

    (1998)
  • JP Carney et al.

    The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: Linkage of double-strand break repair to the cellular DNA damage response

    Cell

    (1998)
  • P Athma et al.

    Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer

    Cancer Genet Cytogenet

    (1996)
  • RA Gatti et al.

    Cancer risk in ATM heterozygotes: A model of phenotypic and mechanistic differences between missense and truncating mutations

    Molec Genet Metab

    (1999)
  • T Fukao et al.

    ATM is upregulated during the mitogenic response in peripheral blood mononuclear cells

    Blood

    (1999)
  • S Gilad et al.

    Genotype–phenotype relationships in Ataxia-telangiectasia and variants

    Am J Hum Genet

    (1998)
  • K Syllaba et al.

    Contribution a l'independence de l'athetose double idiopathique et congenitale: Atteinte familiale, syndrome dystrophique, signe de reseau vasculaire conjonctival, integrite psychique

    Rev Neurol

    (1926)
  • GD Amromin et al.

    Ataxia-telangiectasia with a 32 year survival: A clinicopathological report

    J Neuropathol Exp Neurol

    (1979)
  • E Boder

    Ataxia-telangiectasia: An overview

  • RA Gatti

    Ataxia-telangiectasia

  • RA Gatti et al.

    Localization of an ataxia-telangiectasia gene to chromosome 11q22-23

    Nature

    (1988)
  • E Lange et al.

    Localization of an ataxia-telangiectasia gene to a ∼500 kb interval on chromosome 11q23. 1: Linkage analysis of 176 families in an international consortium

    Amer J Hum Genet

    (1995)
  • K Savitsky et al.

    A single ataxia-telangiectasia gene with a product similar to PI-3 kinase

    Science

    (1995)
  • K Savitsky et al.

    The complete sequence of the ATM gene reveals similarity to cell cycle regulators in different species

    Hum Mol Genet

    (1995)
  • M Telatar et al.

    Ataxia-telangiectasia: Mutations in cDNA detected by protein truncation screening

    Am J Hum Genet

    (1996)
  • ND Lakin et al.

    Analysis of the ATM protein in wild-type and ataxia telangiectasia cells

    Oncogene

    (1996)
  • S Gilad et al.

    Predominance of null mutations in ataxia-telangiectasia

    Human Mol Genet

    (1996)
  • S Castellvi-Bel et al.

    New mutations, polymorphisms and rare variants in the ATM gene detected by a novel SSCP strategy

    Human Mutation

    (1999)
  • J Wright et al.

    A high frequency of distinct ATM gene mutations in ataxia-telangiectasia

    Am J Hum Genet

    (1996)
  • VF Liu et al.

    The ionizing radiation-induced replication protein A phosphorylation response differs between ataxia-telangiectasia and normal human cells

    Mol Cell Biol

    (1993)

    • Cited by (101)

    • Analysis of chromosomal aberrations and γH2A.X foci to identify radiation-sensitive ataxia-telangiectasia patients

      2021, Mutation Research - Genetic Toxicology and Environmental Mutagenesis
      Citation Excerpt :

      In general, most ATM mutations lead to coding of stop codons (seen here in AT8 and AT9), larger deletions (AT6 and AT7) or changed splice points (AT8 and AT9), and fewer than 10% of changes are missense mutations (AT4 and AT5) [14,39,40,42]. As a consequence, no level of ATM protein is detectable in 85% of ATM mutations, even when there is a sufficient amount of mRNA [43]. ATM protein plays a key role in DSB repair, and most symptoms of AT patients are based on defects in DNA damage repair [17,44].

    • The cerebellar degeneration in ataxia-telangiectasia: A case for genome instability

      2020, DNA Repair

    • DNA damage and repair in individuals with ataxia-telangiectasia and their parents

      2018, Mutation Research - Genetic Toxicology and Environmental Mutagenesis
      Citation Excerpt :

      The ATM protein levels in heterozygotes, although lower, are sufficient to ensure normal neurological development and cell functions. The higher cancer risk may be attributed to an ATM threshold below which certain cells become more susceptible to carcinogenic environmental agents [2]. The study of different aspects of AT may provides significant help in the characterization of the disease, allowing changes in the conduct and monitoring of patients, aiming to prevent the emergence of secondary diseases to this pathology, such as the development of cancer [17,18].

    • A novel pathogenic variant in an Iranian Ataxia telangiectasia family revealed by next-generation sequencing followed by in silico analysis

      2017, Journal of the Neurological Sciences

    • A nervous predisposition to unrepaired DNA double strand breaks

      2013, DNA Repair

    • Immunodeficiency Disorders

      2013, Emery and Rimoin's Principles and Practice of Medical Genetics
    View all citing articles on Scopus
    View full text
    Copyright © 2000 Academic Press. All rights reserved.